MAIA Biotechnology, Inc.
MAIA · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $6 | $3 | $3 | $3 |
| G&A Expenses | $3 | $2 | $2 | $2 |
| SG&A Expenses | $3 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $0 | $0 | -$0 |
| Operating Expenses | $9 | $5 | $5 | $5 |
| Operating Income | -$9 | -$5 | -$5 | -$5 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | -$0 | $1 | $1 |
| Pre-Tax Income | -$9 | -$5 | -$5 | -$4 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$9 | -$5 | -$5 | -$4 |
| % Margin | – | – | – | – |
| EPS | -0.27 | -0.18 | -0.16 | -0.14 |
| % Growth | -50% | -12.5% | -14.3% | – |
| EPS Diluted | -0.27 | -0.18 | -0.16 | -0.14 |
| Weighted Avg Shares Out | 33 | 30 | 28 | 26 |
| Weighted Avg Shares Out Dil | 33 | 30 | 28 | 26 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $9 | $0 | $0 | $5 |
| EBITDA | $0 | -$5 | -$5 | $0 |
| % Margin | – | – | – | – |